Clinical-oncological status of patients included in RANIDO clinical trial treated with Racotumomab or Nimotuzumab
Introduction: RANIDO is a clinical trial extended to primary health care with the objective of assessing the efficiency of Cuban biotechnology products Racotumomab and Nimotuzumab for the treatment of non-small cell lung cancer. Objective: to characterize the patients from the clinical and oncologi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidad de Ciencias Médicas de Pinar del Río
2020-06-01
|
| Series: | Universidad Médica Pinareña |
| Subjects: | |
| Online Access: | http://www.revgaleno.sld.cu/index.php/ump/article/view/503 |